Rønnov-Jessen A D, Nielsen P L
Medicinsk-haematologisk afdeling C, Københavns Amts Sygehus i Gentofte.
Ugeskr Laeger. 1991 Nov 4;153(45):3131-4.
Mastocytoses are diseases caused by proliferating mast cells infiltrating one or more organs. The spectrum of mastocytosis includes the cutaneous forms urticaria pigmentosa and solitary mastocytoma (about 90% of mastocytoses) and systemic forms affecting other organs. Infiltrates are most often found in the bone marrow, spleen, lymph nodes and liver, but any organ may be affected. Patients with systemic mastocytosis may or may not have urticaria pigmentosa. About 35% of patients without urticaria pigmentosa have an associated malignant haematological disease and a poor prognosis. Symptoms caused by mast cell mediator release are best treated with antihistamines, but several other drugs may be used if the response is unsatisfactory. Many antineoplastic drugs have been tried to combat aggressive mastocytoses and mast cell leukaemia, but the results have been disappointing.
肥大细胞增多症是由增殖的肥大细胞浸润一个或多个器官引起的疾病。肥大细胞增多症的范围包括皮肤型色素性荨麻疹和孤立性肥大细胞瘤(约占肥大细胞增多症的90%)以及影响其他器官的系统型。浸润最常出现在骨髓、脾脏、淋巴结和肝脏,但任何器官都可能受到影响。系统性肥大细胞增多症患者可能有或没有色素性荨麻疹。约35%没有色素性荨麻疹的患者伴有恶性血液病且预后不良。肥大细胞介质释放引起的症状最好用抗组胺药治疗,但如果反应不令人满意,也可使用其他几种药物。许多抗肿瘤药物已被尝试用于对抗侵袭性肥大细胞增多症和肥大细胞白血病,但结果令人失望。